At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Patent # | Description |
---|---|
2016/0354438 |
THERAPEUTIC AND COSMETIC USES AND APPLICATIONS OF CALRETICULIN The invention relates to therapeutic and cosmetic uses of calreticulin including reducing or eliminating wrinkles and/or fine lines, tissue repair and... |
2016/0354437 |
COMPOSITIONS AND METHODS FOR MODULATION OF IMMUNE RESPONSE Provided herein are compositions and methods for modulation of immune response via PYRIN domain-only proteins POP1 and/or POP3. In particular, POP1 and/or POP3... |
2016/0354436 |
Compositions and Formulations for Increasing Renal Function and Treatment
and Prevention of Renal Diseases, and... Nutritive polypeptides are provided herein. Also provided are various other embodiments including nucleic acids encoding the polypeptides, recombinant... |
2016/0354435 |
NORRIN REGULATION OF JUNCTION PROTEINS AND THE USE THEREOF TO TREAT
EPITHELIAL OR ENDOTHELIAL MEMBRANE LEAKAGE... A method of tightening inter-cellular junctions in endothelial or epithelial cells includes exposing the endothelial or epithelial cells cells to norrin. Upon... |
2016/0354434 |
Methods of Treating Medical Conditions Using Peptides The present invention provides peptides and pharmaceutical compositions thereof for appetite suppression and weight control. Preferred peptides are calcitonin... |
2016/0354433 |
Genetically modified microorganisms Embodiments of the present invention are generally related to genetically modified microorganisms. More specifically, embodiments of the present invention... |
2016/0354432 |
Genetically Modified Microorganisms Embodiments of the present invention are generally related to genetically modified microorganisms. More specifically, embodiments of the present invention... |
2016/0354431 |
COMPOSITIONS FOR PRESERVING INSULIN-PRODUCING CELLS AND INSULIN PRODUCTION
AND TREATING DIABETES Nuclear Transport Modifiers such as cSN50 and cSN50.1, afford in vivo islet protection following a 2-day course of intense treatment in autoimmune... |
2016/0354430 |
HEXADEPSIPEPTIDE ANALOGUES AS ANTICANCER COMPOUNDS This invention relates to a method of treatment of cancer comprising administering compound of Formula (1) or derivatives or pharmaceutically acceptable salts... |
2016/0354429 |
Use of Melanocortins to Treat Insulin Sensitivity The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the... |
2016/0354428 |
METHODS AND COMPOSITIONS RELATED TO INHIBITION OF VIRAL ENTRY Disclosed are compositions and methods for inhibiting viral entry. |
2016/0354427 |
METHODS FOR INDUCING EPITHELIAL CANCER CELL SENESCENCE Systems, methods, and computer readable media for diagnosing or characterizing epithelial cancer or its stages based on the level of expression of the Wnt5a... |
2016/0354426 |
METHODS OF DIAGNOSING AND TREATING ASTHMA The present invention provides materials and methods to diagnose asthma. In some embodiments, the present invention provides a method of diagnosing asthma by... |
2016/0354425 |
METHODS FOR TREATING HCV This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods,... |
2016/0354424 |
COMPOSITIONS AND METHODS FOR TREATMENT OF NEOPLASTIC DISEASE The present invention is concerned with immunostimulant compositions, in particular compositions comprising microparticulate form of muramyl dipeptide, and... |
2016/0354423 |
COLON VITAMIN A colon vitamin includes ingredients that are delivered to different regions of the digestive tract. A first group of ingredients which can include: vitamin D,... |
2016/0354422 |
FOCUS ENHANCING COMPOSITION A focus enhancing composition is provided. The focus enhancing composition includes a plurality of members. The plurality of members at least include... |
2016/0354421 |
SHELF-STABLE OLIVE EXTRACT-CONTAINING COMPOSITIONS AND METHODS OF USE
THEREOF Shelf stable compositions comprising olive extracts are described herein. The compositions include an olive extract comprising hydroxytyrosol, tyrosol, and... |
2016/0354420 |
Oncolytic Adenoviruses for Cancer Treatment The invention relates to an oncolytic adenovirus for the treatment of cancer, containing a human DNA sequence isolating a promoter conferring selective... |
2016/0354419 |
PROBIOTICS FOR USE IN RELIEVING SYMPTOMS ASSOCIATED WITH GASTROINTESTINAL
DISORDERS The present invention provides probiotic compositions suitable for relieving symptoms associated with gastrointestinal disorders. In particular, the present... |
2016/0354418 |
USE OF COMPOSITIONS COMPRISING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS LMG
P-28149 A composition made from at least one probiotic for the use of same in the curative treatment of body weight gain in an overweight human and/or in the... |
2016/0354417 |
SYSTEMS, METHODS, AND COMPOSITIONS RELATING TO COMBIOMICS A process for producing a combiomic complex is disclosed. The process includes: (i) obtaining a pre-combiomic mixture, which includes at least one non-adhered... |
2016/0354416 |
TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA Provided herein are methods of treatment and/or prevention of cancer by manipulation of commensal microflora. In particular, the amount, identity, presence,... |
2016/0354415 |
USE OF UVE BACTERIA FOR GROWTH PROMOTION IN ANIMALS The present invention relates to the use of F4.sup.+ non-pathogenic Escherichia coli strains to promote growth in an animal. The present invention also relates... |
2016/0354414 |
MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF
MANUFACTURE Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are... |
2016/0354413 |
ENCAPSULATED CELLS FOR TREATING LOW TESTOSTERONE IN MALE SUBJECTS A pharmaceutical composition for treating low testosterone comprises microcapsules the microcapsules containing live mammalian ovary cells. The ovary cells... |
2016/0354412 |
USE OF CELLS DERIVED FROM FIRST TRIMESTER UMBILICAL CORD TISSUE A method of isolating a pluripotent cell from human umbilical cord is described herein. The method involves collecting a sample of umbilical cord from fetal... |
2016/0354411 |
OLIVAMINE-INDUCED IMPROVEMENT IN ENDOTHELIAL CELLS VIABILITY AND FUNCTION Compositions for and methods of improving wound healing are disclosed, including compositions for and methods of treating chronic wounds, and compositions for... |
2016/0354410 |
USE OF ANTI THIRD PARTY CENTRAL MEMORY T CELLS FOR ANTI-LEUKEMIA/LYMPHOMA
TREATMENT A method of treating a disease in a subject in need thereof is disclosed. The method comprising: (a) transplanting a non-syngeneic cell or tissue graft to the... |
2016/0354409 |
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN, NY
ESO-1 The present invention discloses the identification and isolation of novel MHC class II epitopes derived from the cancer antigen, NY ESO-1. The novel MHC class... |
2016/0354408 |
MICRO-ORGANOIDS, AND METHODS OF MAKING AND USING THE SAME Provided herein are micro-organoids, referred to herein as Functional Physiological Units (FPUs), that are capable of replacing or augmenting one or more... |
2016/0354407 |
Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In
Combination With Certain Wavelengths... Formulations of antimicrobial, antiviral, and antineoplastic compounds in combination with certain wavelengths of light include a solution that includes an... |
2016/0354406 |
BIODEGRADABLE CONTROL OF BACTERIAL CELLULOSE BY RADIATION TECHNOLOGY AND
ABSORBABLE PERIODONTAL MATERIAL USING SAME An absorbable periodontal tissue and bone regeneration material uses bacterial cellulose that has been exposed to radiation. The bacterial cellulose was... |
2016/0354405 |
METHOD TO PREPARE GANODERMA LUCIDUM POLYSACCHARIDES POSSESSING
INSULIN-SENSITIZING PROPERTIES AND APPLICATIONS... The present invention provides a method to prepare polysaccharides from Ganoderma lucidum. The prepared polysaccharides can reduce hyperglycemia and improve... |
2016/0354404 |
Compositions and Methods for Inhibition of PCSK9 Genes The invention relates to sirens targeting a PCs gene, and methods of using sirens to inhibit expression of PCs and to treat PCs related disorders, e.g.,... |
2016/0354403 |
ENDOTHELIAL CELL GENES AND USES THEREOF Disclosed herein are genes which are differentially expressed in venule endothelial cells (V-ECs) compared to non-venule endothelial cells (NV-ECs) and... |
2016/0354402 |
COMPOSITIONS The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use as an anticonvulsant and/or seizure... |
2016/0354401 |
URIDINE DIPHOSPHATE COMPOUNDS AS MOBILIZERS OF HEMATOPOIETIC PROGENITOR
CELLS The present invention provides for compositions and methods for administering one or more UDP compound, alone or in combination with another hematopoietic... |
2016/0354400 |
NUCLEOSIDE PHOSPHORAMIDATES Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent RNA viral... |
2016/0354399 |
SUBSTITUTED GEMCITABINE ARYL AMIDE ANALOGS In accordance with the purpose(s) of the invention, as embodied and broadly described herein, the invention, in one aspect, relates to substituted gemcitabine... |
2016/0354398 |
ADJUVANT CONTAINING BAICALIN, PARTICULARLY FROM A SCUTELLARIA BAICALENSIS
EXTRACT, AND ANIMAL FEED CONTAINING... A nutritional adjuvant intended to improve the production performance in farmed animals in a situation of stress, consisting of baicalin and/or baicalein... |
2016/0354397 |
METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF
ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS This invention provides methods, processes, compounds and compositions for modulating the gene expression or secretion of adhesion proteins, angiopoietins or... |
2016/0354396 |
THERAPEUTIC COMPOSITION This invention relates to a topical composition for prevention and treatment of viral infections. |
2016/0354395 |
INFANT FORMULAS CONTAINING A 2-FUCOSYLATED OLIGOSACCHARIDE FOR TREATMENT
OR PREVENTION OF INFLUENZA INFECTION Compositions for use in the treatment or prevention of influenza infection are provided, and the compositions contain a 2-fucosylated oligosaccharide, such as... |
2016/0354394 |
Compositions and Methods for Inhibiting Inflammation and Diseases Using an
Alginic Acid-Based Antimicrobial... The present disclosure relates to compositions and methods for inhibiting inflammation and reducing the risk of spreading sexually transmitted diseases using... |
2016/0354393 |
PHARMACEUTICAL COMPOSITION INCLUDING MIGRATORY FACTOR FOR GUIDING
PLURIPOTENT STEM CELLS TO DAMAGE The purpose of the present invention is to identify a migratory factor that guides pluripotent stem cells (Muse cells) useful in new medical applications to... |
2016/0354392 |
MITOCHONDRIA-TARGETED ANTIOXIDANTS FOR TREATMENT OF AGE-RELATED BRAIN
DISORDERS A method for providing to a mammal a neuroprotective effect against a brain pathology that is associated with reactive oxygen species originating from... |
2016/0354391 |
USE IN SINGLE PILL/TABLET/CAPSULE OF MINOCYCLINE, FLUCONAZOLE AND
ATORVASTATIN IN THE TREATMENT OF MULTIPLE... The present invention has for object the use of minocycline or its equivalent forms, or of any form of tetracycline in combination with Fluconazole or any of... |
2016/0354390 |
PARENTAL COMPOSITIONS OF CELECOXIB Parenteral (injectable) celecoxib emulsions and nanoemulsions are disclosed as are their use to treat pain in patients so afflicted. The emulsions are... |
2016/0354389 |
NOVEL CRYSTALS AND PROCESS OF MAKING 5-(-METHYL)-2-METHOXY-BENZOIC ACID The present invention relates to a novel crystals of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-- ... |